Collectively, these results suggest that dezocine might inhibit the expression of CRABP2 by targeting the Akt/mTOR signaling pathway, and ultimately regulate the proliferation and migration of ovarian cancer cells. The gene discussed is MTOR; the disease is ovarian carcinoma.